TUESDAY, April 12, 2022 (HealthDay News) — Certain personality traits may make older adults more or less vulnerable to waning memory and thinking skills, a new study suggests. The study, of nearly 2,000 older adults, found that those high on the “conscientious” scale — organized, self-disciplined and productive — wereContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Psilocybin — the active component in “magic mushrooms” — may help rewire the brains of people with depression. Psychedelics including psilocybin have shown promise in treating many mental health disorders in recent years, and a new study is among the first to beginContinue Reading
TUESDAY, April 12, 2022 (American Heart Association News) — At their babies’ 20-week ultrasound, Bridget and Jerrid Conway were eager to catch another glimpse of their twin girls. In the exam room, the technician moved the wand over Bridget’s stomach. When she lingered over Twin A, or Sadie as theyContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week. City officials announced the change on Monday, as COVID-19 cases have climbed across the country due to the highly transmissible Omicron subvariant known asContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. The medication, sabizabulin, halved the death rate in COVID-19 patientsContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — In their search for a drug to prevent Alzheimer’s disease, scientists are taking a look at certain rheumatoid arthritis drugs. Preliminary findings suggest that a type of rheumatoid arthritis drug known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients whoContinue Reading
New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more Philadelphia Becomes First USContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — If you suffer from headaches, you have plenty of company. Headaches afflict half of the world’s population, and women are more likely to get them than men, a new paper says. “We found that the prevalence of headache disorders remains high worldwide andContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Quitting smoking can give heart disease patients nearly five additional years of life without heart problems, according to a new study. “Kicking the habit appears to be as effective as taking three medications for preventing heart attacks and strokes in those with aContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — The pandemic has worsened longstanding staffing shortages at U.S. nursing homes and other long-term care facilities. Now, a new study shows that high employee turnover rates have yet to improve. Researchers found that after initial workforce losses in the early phase of theContinue Reading